Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,099 results that match your search.22,099 results
  • The US government released its 2014 Special 301 Report today, with India remaining on the list of countries the US considers to have inadequate IP protection but avoiding being downgraded to the worst classification
  • The EU’s competition commissioner has confirmed that owners of standard-essential patents can seek injunctions if they believe their rights have been infringed, but explained how such applications for injunctions might be deemed to be abusive
  • There was a lot of interest in our quiz on IP in the movies last week. If you want to know the answers to all 15 questions, read on. If not, look away now
  • Brazil has moved up to fifth in the rankings of countries with the most trade mark publications annually. At the same time, its patent and trade mark office is making changes to cope with the rapid change
  • Pedro Vilhena of Kasznar Leonardos compares Brazilian and Chinese developments in trade mark law in the face of major sporting events, and suggests how Brazil should take heed of its eastern counterpart
  • Eduardo Otero and André Oliveira of Daniel Advogados explain the more efficient, longer-lasting, but more expensive procedures for highly-renowned marks in Brazil
  • The Supreme Court will consider the issue of joint patent infringement in Limelight Networks v Akamai Technologies, a case with interesting ramifications for online companies and their customers. But who is responsible for plugging perceived loopholes in patent law?
  • The Supreme Court has unanimously reversed the Federal Circuit and rejected the Brooks Furniture framework for fee shifting in Octane v Icon, while holding that all aspects of a district court’s exceptional-case determination should be reviewed for abuse of discretion in Highmark v Allcare
  • The Court of Justice of the EU will begin hearings in a case today that should see it offer scientists and their patent advisers more certainty about the patentability of stem cells
  • In an interview with Managing IP, Alka Mehta, head of the formulation patent department at Indian pharmaceutical manufacturer Cipla, says that, notwithstanding its reputation as one of the world’s largest generics, companies such as Cipla also rely on patent protection in India and around the world